Francisca
Lago Paz
Publications by the researcher in collaboration with Francisca Lago Paz (10)
2024
-
Cardiometabolic effects of sacubitril/valsartan in a rat model of heart failure with preserved ejection fraction
Biochemical Pharmacology, Vol. 230
2023
-
Poly(ethylene Glycol) Methyl Ether Methacrylate-Based Injectable Hydrogels: Swelling, Rheological, and In Vitro Biocompatibility Properties with ATDC5 Chondrogenic Lineage
Polymers, Vol. 15, Núm. 24, pp. 4635
-
Role of Soluble ST2 Biomarker in Predicting Recurrence of Atrial Fibrillation after Electrical Cardioversion or Pulmonary Vein Isolation
International Journal of Molecular Sciences, Vol. 24, Núm. 18
-
The lipidomic and inflammatory profiles of visceral and subcutaneous adipose tissues are distinctly regulated by the SGLT2 inhibitor empagliflozin in Zucker diabetic fatty rats
Biomedicine and Pharmacotherapy, Vol. 161
2022
-
Relaxin-2 plasma levels in atrial fibrillation are linked to inflammation and oxidative stress markers
Scientific Reports, Vol. 12, Núm. 1
-
The Treatment With the SGLT2 Inhibitor Empagliflozin Modifies the Hepatic Metabolome of Male Zucker Diabetic Fatty Rats Towards a Protective Profile
Frontiers in Pharmacology, Vol. 13
2021
-
Evaluation of Virola oleifera activity in musculoskeletal pathologies: Inhibition of human multiple myeloma cells proliferation and combination therapy with dexamethasone or bortezomib
Journal of Ethnopharmacology, Vol. 272
-
Pharmacological Extracts and Molecules from Virola Species: Traditional Uses, Phytochemistry, and Biological Activity
Molecules (Basel, Switzerland), Vol. 26, Núm. 4
2019
-
Empagliflozin reduces the levels of CD36 and cardiotoxic lipids while improving autophagy in the hearts of Zucker diabetic fatty rats
Biochemical Pharmacology, Vol. 170
-
Hydrocortisone loaded poly-(3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for topical ophthalmic administration: Preparation, characterization and evaluation of ophthalmic toxicity
International Journal of Pharmaceutics, Vol. 568